Literature DB >> 18506054

Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians.

Willem J Remme1, John J V McMurray, F D Richard Hobbs, Alain Cohen-Solal, José Lopez-Sendon, Alessandro Boccanelli, Faiez Zannad, Bernhard Rauch, Karen Keukelaar, Cezar Macarie, Witold Ruzyllo, Charles Cline.   

Abstract

AIMS: To assess awareness of heart failure (HF) management recommendations in Europe among cardiologists (C), internists and geriatricians (I/G), and primary care physicians (PCPs). METHODS AND
RESULTS: The Study group on HF Awareness and Perception in Europe (SHAPE) surveyed randomly selected C (2041), I/G (1881), and PCP (2965) in France, Germany, Italy, the Netherlands, Poland, Romania, Spain, Sweden, and the UK. Each physician completed a 32-item questionnaire about the diagnosis and treatment of HF (left ventricular ejection fraction <40%). This report provides an analysis of HF awareness among C, I/G, and PCP. Seventy-one per cent I/G and 92% C use echocardiography, and 43% I/G and 82% C use echo-Doppler as a routine diagnostic test (both P < 0.0001). In contrast, 75% PCP use signs and symptoms to diagnose HF. Fewer I/G would use an angiotensin-converting enzyme (ACE)-inhibitor in >90% of their patients (64 vs. 82% C, P < 0.0001), whereas only 47% PCP would routinely prescribe an ACE-inhibitor. Worsening HF was considered a risk of ACE-inhibitor therapy by 35% PCP. I/G and PCP consistently do not prescribe target ACE-inhibitor doses (P < 0.0001 vs. C). Only 39% I/G would use a beta-blocker in >50% of their patients (vs. 73% C, P < 0.0001). Also, only 5% PCP would always, and 35% often, prescribe a beta-blocker and reach target doses in only 7-29%. Moreover, 34% PCP and 26% I/G vs. 11% C (P < 0.0001) do not start a beta-blocker in patients with mild HF, who are already on an ACE-inhibitor and are on diuretic. In mild, stable HF, 39% PCP and 18% I/G would only prescribe diuretics, vs. 7% C (P < 0.0001). In patients with worsening HF in sinus rhythm and on an optimal ACE-inhibitor, beta-blockade and diuretics, significantly more C would add spironolactone, but I/G would more often add digoxin.
CONCLUSION: Although each physician group lacks complete adherence to guideline-recommended management strategies, these are used significantly less well by I, G, and PCPs, indicating the need for education of these essential healthcare providers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506054     DOI: 10.1093/eurheartj/ehn196

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  31 in total

1.  Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.

Authors:  Yevgeniy Khariton; Adrian F Hernandez; Gregg C Fonarow; Puza P Sharma; Carol I Duffy; Laine Thomas; Xiaojuan Mi; Nancy M Albert; Javed Butler; Kevin McCague; Michael E Nassif; Fredonia B Williams; Adam DeVore; J Herbert Patterson; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-04

2.  [Chronic cardiac insufficiency in the elderly].

Authors:  D Fischer; A Dettmer-Flügge; R Thiesemann; M Gogol
Journal:  Z Gerontol Geriatr       Date:  2011-06       Impact factor: 1.281

Review 3.  Systolic heart failure: knowledge gaps, misconceptions, and future directions.

Authors:  Rohan Samson; Rohit Ramachandran; Thierry H Le Jemtel
Journal:  Ochsner J       Date:  2014

Review 4.  Heart failure management in the elderly - a public health challenge.

Authors:  Natasa Cvetinovic; Goran Loncar; Jerneja Farkas
Journal:  Wien Klin Wochenschr       Date:  2016-11-29       Impact factor: 1.704

Review 5.  [The telemedical service centre as an essential element of the conceptual approach for telemonitoring of cardiac patients : Requirements on the service, quality, and technical realization of telemonitoring].

Authors:  T M Helms; A Müller; C Perings; F Köhler; V Leonhardt; K Rybak; S Sack; M Stockburger
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-08-24

6.  Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents: For the Many or the Few?

Authors:  Massimo Leggio; Augusto Fusco; Claudia Loreti; Giorgio Limongelli; Maria Grazia Bendini; Andrea Mazza; Antonio Frizziero; Daniele Coraci; Luca Padua
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

7.  Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure.

Authors:  Tamara B Horwich; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

8.  Route to heart failure diagnosis in English primary care: a retrospective cohort study of variation.

Authors:  Dani Kim; Benedict Hayhoe; Paul Aylin; Azeem Majeed; Martin R Cowie; Alex Bottle
Journal:  Br J Gen Pract       Date:  2019-09-26       Impact factor: 5.386

9.  Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers.

Authors:  J T Vehmeijer; I Christiaans; I M van Langen; E Birnie; G J Bonsel; E M A Smets; A A M Wilde
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

10.  Overdiagnosis of heart failure in primary care: a cross-sectional study.

Authors:  Mark J Valk; Arend Mosterd; Berna Dl Broekhuizen; Nicolaas Pa Zuithoff; Marcel Aj Landman; Arno W Hoes; Frans H Rutten
Journal:  Br J Gen Pract       Date:  2016-06-06       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.